Safety of the Hepatitis B Vaccine

New England Journal of Medicine

Volumn 312, Issue 6, 1985, Pages 375-376

  Stevens, Cladd E ^a   Taylor, Patricia E ^a   Rubinstein, Pablo ^a   Ting, Robert C y ^b   Bodner, Anne J ^b   Sarngadharan, M G ^c   Gallo, Robert C ^d   Dienstag, Jules L ^e  

^a NEW YORK BLOOD CENTER   (United States)

^b Biotech Research Laboratories   (United States)

^c Litton Bionetics ^*  (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; PLACEBO;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG SAFETY; HOMOSEXUALITY; HUMAN; LIVER; PREVENTION; PRIORITY JOURNAL; SAFETY;

ANTIBODIES, VIRAL; DELTARETROVIRUS; HEPATITIS B VACCINES; HUMANS; MALE; VIRAL HEPATITIS VACCINES;

EID: 0021922383     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198502073120613     Document Type: Letter

References (10)

1. Jacobson IM, Dienstag JL, Zachoval R, Hanrahan BA, Watkins E, Rubin RH. Lack of effect of hepatitis B vaccine on T-cell phenotypes. N Engl J Med 1984; 311: 1030–2.
2. Inactivated hepatitis B virus vaccine. MMWR 1982; 31: 317–28.
3. Gallo RC, Salahuddin SZ, Popovic M, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224: 500–3.
4. Safai B, Sarngadharan MG, Groopman JE, et al. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome. Lancet 1984; 1: 1438–40.
5. Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303: 833–41.
6. Stevens CE. No increased incidence of AIDS in recipients of hepatitis B vaccine. N Engl J Med 1983; 308: 1163–4.
7. Saxinger C, Gallo RC. Methods in laboratory investigation: application of the indirect enzyme-linked immunosorbent assay microtest to the detection and surveillance of human T cell leukcmia-lymphoma virus. Lab Invest 1983; 49: 371–7.
8. Sarngadharan MG, Popovic M, Bruch L, Schüpbach J, Gallo RC. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science 1984; 224: 506–8.
9. Poiesz B, Tomar R, Lehr B, Moore J. Hepatitis B vaccine: evidence confirming lack of AIDS transmission. MMWR 1984; 33: 685–7.
10. Dienstag JL, Werner BG, Polk BF, et al. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med 1984; 101: 34–40.